AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 182 filers reported holding AMAG PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 6.30 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $708,000 | +6.6% | 58,200 | +1.2% | 0.01% | +20.0% |
Q3 2019 | $664,000 | +262.8% | 57,500 | +214.6% | 0.01% | +400.0% |
Q2 2019 | $183,000 | -69.5% | 18,275 | -39.1% | 0.00% | -75.0% |
Q3 2018 | $600,000 | -66.0% | 30,000 | -40.9% | 0.00% | -60.0% |
Q4 2016 | $1,766,000 | +99.5% | 50,761 | +40.6% | 0.01% | +100.0% |
Q3 2016 | $885,000 | +26.8% | 36,100 | +105.4% | 0.01% | +66.7% |
Q3 2015 | $698,000 | -82.7% | 17,579 | -69.9% | 0.00% | -85.7% |
Q2 2015 | $4,029,000 | +439.4% | 58,341 | +327.1% | 0.02% | +425.0% |
Q1 2015 | $747,000 | -75.1% | 13,660 | -80.6% | 0.00% | -77.8% |
Q4 2014 | $2,999,000 | +299800.0% | 70,354 | +305787.0% | 0.02% | – |
Q3 2014 | $1,000 | – | 23 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Broadfin Capital, LLC | 3,921,550 | $81,254,000 | 4.00% |
Palo Alto Investors LP | 1,614,536 | $33,453,000 | 2.49% |
Ghost Tree Capital, LLC | 100,000 | $2,072,000 | 1.46% |
March Altus Capital Management LP | 146,418 | $3,034,000 | 1.11% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 296,458 | $6,143,000 | 0.98% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 999,339 | $20,706,000 | 0.83% |
Visium Asset Management, LP | 2,070,870 | $42,908,000 | 0.67% |
AlphaOne Investment Services, LLC | 97,448 | $2,019,000 | 0.54% |
CONTINENTAL ADVISORS LLC | 57,438 | $1,190,000 | 0.28% |
Tamarack Capital Management, LLC | 64,080 | $1,222,000 | 0.25% |